Applied therapeutics reports first quarter 2024 financial results

New york, may 09, 2024 (globe newswire) -- applied therapeutics, inc. (nasdaq: aplt) (the “company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results for the first quarter ended march 31, 2024.
APLT Ratings Summary
APLT Quant Ranking